HomeCABA • NASDAQ
add
Cabaletta Bio Inc
Previous close
$1.81
Day range
$1.65 - $2.16
Year range
$0.99 - $13.50
Market cap
103.01M USD
Avg Volume
1.15M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 37.14M | 32.48% |
Net income | -35.94M | -43.50% |
Net profit margin | — | — |
Earnings per share | -0.71 | -39.22% |
EBITDA | -36.65M | -32.61% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 131.83M | -41.11% |
Total assets | 165.14M | -31.32% |
Total liabilities | 43.59M | 132.63% |
Total equity | 121.55M | — |
Shares outstanding | 50.62M | — |
Price to book | 0.75 | — |
Return on assets | -53.02% | — |
Return on capital | -58.34% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -35.94M | -43.50% |
Cash from operations | -30.80M | -28.41% |
Cash from investing | -785.00K | 3.33% |
Cash from financing | -552.00K | -108.05% |
Net change in cash | -32.13M | -79.06% |
Free cash flow | -26.06M | -58.85% |
About
Founded
2017
Headquarters
Website
Employees
163